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One-sentence summary: Two distinct P2Y receptors are required for full activation of platelet integrin 
and fibrinogen binding. 
 
Editor’s summary: 
Ca2+ waves and integrin activation 
The integrin GPIIb/IIIa is highly abundant on the surface of platelets and can be activated by intracellular 
Ca2+ signaling in an “inside-out” manner to bind to the adhesive ligand fibrinogen. Bye et al. imaged 
intracellular Ca2+ signaling and fibrinogen binding events in primary rat megakaryocytes activated through 
the ADP-stimulated receptors P2Y1 and P2Y12. The authors found that signaling by both receptors was 
required for full integrin activation, which depended on P2Y1-stimulated Ca2+ signaling and P2Y12-
stimulated activation of the kinase PI3K. In addition, fibrinogen binding became polarized in these cells in 
a manner dependent on the direction of ADP-stimulated Ca2+ waves. 
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Abstract 
Cells sense extracellular nucleotides through the P2Y class of purinergic G protein–coupled 
receptors (GPCRs), which stimulate integrin activation through signaling events, including 
intracellular Ca2+ mobilization. We investigated the relationship between P2Y-stimulated 
repetitive Ca2+ waves and fibrinogen binding to the platelet integrin αIIbβ3 (GPIIb/IIIa) through 
confocal fluorescence imaging of primary rat megakaryocytes. Costimulation of the receptors 
P2Y1 and P2Y12 generated a series of Ca2+ transients that each induced a rapid, discrete increase 
in fibrinogen binding. The peak and net increase of individual fibrinogen binding events correlated 
with the Ca2+ transient amplitude and frequency, respectively. Using BAPTA loading and selective 
receptor antagonists, we found that Ca2+ mobilization downstream of P2Y1 was essential for ADP-
evoked fibrinogen binding, whereas P2Y12 and the kinase PI3K were also required for αIIbβ3 
activation and enhanced the number of Ca2+ transients. ADP-evoked fibrinogen binding was 
initially uniform over the cell periphery but subsequently redistributed with a polarity that 
correlated with the direction of the Ca2+ waves. Polarization of αIIbβ3 may be mediated by the actin 
cytoskeleton, because surface-bound fibrinogen is highly immobile, and its motility was enhanced 
by cytoskeletal disruption. In conclusion, spatial and temporal patterns of Ca2+ increase enable fine 
control of αIIbβ3 activation after cellular stimulation. P2Y1-stimulated Ca2+ transients coupled to 
αIIbβ3 activation only in the context of P2Y12 co-activation, thereby providing an additional 
temporal mechanism of synergy between these Gq- and Gi-coupled GPCRs. 
 
Introduction 
The αIIbβ3 integrin (GPIIb/IIIa) is one of the most highly expressed platelet surface proteins and 
has a key role in hemostasis through its ability to bind to several adhesive ligands, particularly 
fibrinogen and von Willebrand factor (1). Blood cell integrins exhibit a low affinity for their ligands 
under resting conditions; however, “inside-out” activation after adequate cellular signaling 
induces a conformational change that promotes the high-affinity state and thus ligand binding 
(2). Among the signaling events that couple platelet receptors to αIIbβ3 integrin activation, 
cytosolic Ca2+ flux plays a crucial role through its ability to stimulate the Ca2+-sensor CalDAG-GEFI 
and thus also the small G protein Rap1 (3, 4). Sufficient activation of Rap1 promotes the binding 
of talin to αIIbβ3 to shift the integrin into its high-affinity state (5-8). However, GTP loading of Rap1 
by CalDAG-GEFI is opposed by the constitutive GAP activity of RASA3; thus, αIIbβ3 integrin 
activation downstream of phospholipase-C (PLC)-coupled receptors is limited unless 
accompanied by phosphoinositide 3-kinase (PI3K)-induced inhibition of RASA3, for example after 
stimulation of Gαi-coupled P2Y12 receptors (5). 
 Intracellular Ca2+ responses do not occur as uniform increases throughout the cytoplasm, but 
instead display complex spatiotemporal patterns in the form of restricted punctate events, 
oscillations, and waves (9, 10). Several studies have demonstrated the functional relevance of 
the spatial and temporal information within these cytosolic Ca2+ increases. For example, the 
frequency of oscillations determines both the efficiency and specificity of gene transcription in 
lymphocytes (11), and unitary Ca2+ events can play different roles compared to those of global 
Ca2+ increases during smooth muscle contraction (12). Ca2+ waves promote intracellular signaling 
over a long distance in large cells (13-15) and coordinate certain types of cardiac myocyte 
contraction (16). In the platelet, Ca2+ transients triggered by environmental stimuli induce 
procoagulant activity (17, 18) in a manner that is dependent upon the Ca2+ spiking pattern of the 
individual cell (19, 20). However, the relationship between the spatiotemporal patterns of 
cytosolic Ca2+ signals and inside-out integrin activation is unclear. 
 
Previous reports have raised concerns that cell culture systems do not fully reproduce the events 
underlying agonist-evoked integrin activation in highly specialized cells such as platelets (21). 
Here, we used freshly isolated megakaryocytes (MKs) as a primary cell type that displays 
repetitive Ca2+ waves (22, 23) and robust inside-out activation of the αIIbβ3 integrin (24, 25) to 
investigate the interaction between these two events. We showed that transient Ca2+ waves 
downstream of P2Y1 receptors coupled to αIIbβ3 activation within seconds, but only when P2Y12 
receptors were co-stimulated. The extent of fibrinogen binding was dependent upon both the 
amplitude and interval of the Ca2+ transient. Although ionophore-generated, sustained Ca2+ 
increases alone activated the integrin, this occurred with a substantial delay. Thus, the 
acceleration of Ca2+-dependent inside-out αIIbβ3 activation by P2Y12 receptors represents a key 
component of the synergy between Gq- and Gi-coupled P2Y receptors. We also provide evidence 
that the net direction of the ADP-evoked Ca2+ waves may explain the polarization of fibrinogen 
binding observed during the later stages of this functional response. 
 
Results 
P2Y-evoked Ca2+ transients mediate precise temporal activation of αIIbβ3 
To investigate the relationship between intracellular Ca2+ and αIIbβ3 activation, primary rat MKs 
were exposed to a hydrolysis-resistant ligand of both P2Y1 and P2Y12 receptors, ADPβS, which 
avoids the loss of agonist due to ectonucleotidase activity in Ca2+-containing external saline (26). 
ADPβS evoked a series of transient increases in whole-cell intracellular Ca2+ and stimulated 
fibrinogen binding at the plasma membrane, which served as a marker for activation of the 
integrin αIIbβ3 (Fig. 1A and movie S1). Peripheral fibrinogen binding increased in a stepwise 
manner that coincided with the occurrence of [Ca2+]i transients (Fig. 1B). Upon closer analysis, a 
discrete increase in fibrinogen binding (Fig. 1C) was found to follow each [Ca2+]i transient (Fig. 
1D). It was therefore possible to quantify the properties of each αIIbβ3 activation event in terms 
of the peak increase in fibrinogen binding (Peak ΔF) and the net change in fibrinogen binding 
between successive [Ca2+]i transients (Net ΔF). We also quantified the peak of each [Ca2+]i 
transient (Peak ΔF/F0) and the interval between transients. Correlation was observed between 
the maximum increase in fibrinogen binding (Peak ΔF) and the peak increase in Ca2+ (Peak ΔF/F0) 
in 91% of MKs (Fig. 1E). This indicates that the amplitude of the Ca2+ transient determines the 
magnitude of αIIbβ3 activation. A statistically significant correlation was also observed between 
the net change in bound fibrinogen at the end of the period between successive Ca2+ transients 
(Net ΔF) and the interval of the Ca2+ transient in 75% of MKs (Fig. 1F). This further suggests that 
the frequency of Ca2+ transients determines whether a net accumulation or reduction in the 
amount of activated, fibrinogen-bound integrin αIIbβ3 occurs between successive Ca2+ transients. 
The gradient describing this relationship was not statistically significantly different between 
individual MKs (mean value: -1.28ΔFs-1 ± 0.518). The x-intercept, which reflects the inter-
transient interval below which the net fibrinogen binding switches from an increase to a 
decrease, varied between different cells (range: 12 to 44 s) as expected from the intercellular 
heterogeneity in the magnitude of the Ca2+ responses and thus also the fibrinogen-binding 
events. Together, these data suggest that Ca2+ transients promote both the immediate and the 
cumulative activation of αIIbβ3 through both their amplitude and frequency of occurrence. 
 
P2Y1-dependent repetitive Ca2+ increases stimulate αIIbβ3 activation only in combination with 
P2Y12-dependent signaling 
Individual Ca2+ transients evoked by P2Y receptors stimulated a finite increase in integrin αIIbβ3 
activation after a mean delay of 2.9 ± 0.75 s [measured from initiation of the [Ca2+]i transient to 
the onset of fibrinogen binding; (Fig. 2, A and B)]. Loading of MKs with the Ca2+ chelator BAPTA 
to an extent sufficient to prevent a detectable ADPβS-evoked Ca2+ increase abolished the 
fibrinogen binding event (Fig. 2C). This confirms previous evidence that increased [Ca2+]i is an 
essential component of the P2Y receptor signaling events leading to integrin αIIbβ3 activation (27, 
28). Overlay of the integral of the [Ca2+]i increase further highlighted the close association of this 
cytosolic signal with subsequent integrin activation and the consistent lag between the two 
events across multiple transients (Fig. 2D). 
 
ADP stimulates two receptors in platelets, P2Y1 and P2Y12, which couple to Gq and Gi, 
respectively (29-35). The selective P2Y1 antagonist MRS2179 ablated both ADPβS-evoked Ca2+ 
signaling and integrin αIIbβ3 activation (Fig. 2E). In contrast, ADPβS still stimulated a Ca2+ response 
in the presence of a maximal concentration of the P2Y12 antagonist, Cangrelor, although 
fibrinogen binding was similarly abolished (Fig. 2F). Thus, signaling downstream of both P2Y1 and 
P2Y12 is required for activation of integrin αIIbβ3 by ADPβS in the rat MK, as was previously 
observed in platelets and murine MKs (25, 26, 30-33, 35, 36). The number of Ca2+ transients was 
reduced from 22 per 9-minute period in control settings to only 1 to 3 transients per recording 
after blockade of P2Y12 receptors, indicating the ability for this Gi-coupled receptor to prolong 
the Ca2+ response. A direct enhancement of a sustained [Ca2+]i increase in response to the 
ionophore ionomycin also induced peripheral fibrinogen binding (Fig. 2G and movie S2). This 
indicates that a prolonged increased amount of intracellular Ca2+ stimulates inside-out activation 
of αIIbβ3, consistent with a previous study of platelet aggregation (37). However, despite 
stimulating a larger peak Ca2+ increase than that observed in response to ADPβS (Fig. 2A), the 
ionomycin-evoked fibrinogen binding occurred with a statistically significantly greater delay 
compared to P2Y receptor stimulation (23.6 ± 12.3 s vs 2.9 ± 0.75 s after the initial Ca2+ increase, 
respectively, Fig. 2H). In addition, stimulation of P2Y12 with ADPβS together with ionomycin 
under conditions of P2Y1 receptor blockade with MRS 2179 (Fig. 2I) had no statistically significant 
effect on the rate of onset of αIIbβ3 activation compared to that in response to ionomycin alone 
(Fig. 2J). This suggests that an additional signal downstream of P2Y1 or a difference between the 
spatiotemporal pattern of the ADP-evoked versus the ionomycin-stimulated Ca2+ increase 
contributes to the ability of this Gq-coupled receptor to synergize with P2Y12 in the acceleration 
of αIIbβ3 activation. 
 
Synergy between Ca2+ transients and PI3K signaling is required for the activation of αIIbβ3 
We next explored the mechanism responsible for temporal synergy between P2Y1 and P2Y12 
during ADP-dependent αIIbβ3 activation in experiments with pharmacological inhibitors of 
signaling events downstream of these receptors. In MKs and platelets, the Gq-coupled P2Y1 
receptor is required for the Ca2+ response through its coupling to phospholipase-C (PLC) and thus 
stimulation of IP3-dependent Ca2+ mobilization (25, 29, 33). We found that both the [Ca2+]i 
increase and the fibrinogen binding evoked by ADPβS (Fig. 3A) were ablated by incubation with 
the PLC inhibitor U73122, whereas the structurally related, non-PLC inhibiting analog U73343 
had no effect (Fig. 3, B and C). P2Y1 receptors also release diacylglycerol (DAG) and thus stimulate 
protein kinase C (PKC); however, the pan-PKC inhibitor GF109203 had no effect on ADPβS-
stimulated fibrinogen binding (Fig. 3D). GF109203 modified the Ca2+ response by preventing its 
return to baseline between [Ca2+]I transients, which is likely a consequence of the role of PKC in 
mediating P2Y1 receptor desensitization and internalization (38, 39). The ability of P2Y12 
receptors to modulate the P2Y1-dependent Ca2+ response has been suggested previously to be 
mediated through activation of PI3K and also inhibition of adenylyl cyclase (AC), although 
amplification of [Ca2+]i by AC inhibition requires co-stimulation of Gs-coupled receptors (40, 41). 
Roles for both PI3Kβ and PI3Kγ in P2Y12-mediated integrin activation have been demonstrated 
using both pharmacological tools and isoform-specific knockout mice (30, 42). Consistent with 
these previous observations, we found that the pan-PI3K inhibitor LY294002 mimicked the action 
of Cangrelor by abolishing the fibrinogen response (Fig. 3E), confirming the crucial role for PI3K 
in P2Y12-evoked integrin αIIbβ3 activation (43-45). LY294002 also limited the Ca2+ response to 
only 1 to 2 transients. In contrast, inhibition of AC with SQ22536 did not enhance the ADP-evoked 
Ca2+ response (Fig. 3F) or rescue it in the presence of Cangrelor (Fig. 3, G and H). Because PI3K 
proved critical for ADPβS-evoked activation of αIIbβ3, we treated MKs with LY294002 before 
stimulation with ionomycin and found that fibrinogen binding still occurred but only after a 
statistically significantly increased delay (235 ± 96 s) relative to that in vehicle-treated MKs (Fig. 
3I). This effect can be explained by an ability of ionophore-induced [Ca2+]i increases to directly 
activate PI3K (46). Ionomycin-induced fibrinogen binding was totally abolished by the PLC 
inhibitor U73122 (Fig. 3J), but not by the control analog U73343 (Fig. 3K), which is consistent with 
the reported ability of a large sustained [Ca2+]i increase to activate this Gq-coupled enzyme in 
platelets (47). Together, these results indicate a nonredundant role for PLC in the pathways 
leading to αIIbβ3 activation, consistent with effects observed in patients with a platelet-specific 
deficiency in PLCβ (48-50). 
 
P2Y-evoked Ca2+ waves promote spatial reorganization of activated αIIbβ3 
In primary MKs, the transient Ca2+ increases occurred as waves that traveled across the cytosol 
(22, 23) and had a clear point of origin and direction of travel (Fig. 4A). Because [Ca2+]i transients 
are critical in determining the temporal pattern of αIIbβ3 activation, we investigated whether the 
waves also modulated the spatial characteristics of fibrinogen binding. The net direction of the 
Ca2+ waves in each cell was analyzed by calculating a Ca2+ polarity score. A value of 1 represents 
an MK in which all of the Ca2+ waves travelled in the same direction, whereas a score of 0 
represents an MK in which there was no net dominant directionality. We generated images of 
the first ten Ca2+ waves as well as the radar plots to illustrate the percentage of waves travelling 
in each direction throughout a recording for a cell with a low Ca2+ polarity score (Fig. 4, B and C) 
and for a cell with a high score (Fig. 4, D and E). Heterogeneity in different MKs was observed in 
the Ca2+ polarity score, which ranged from 0.73 to 0.08 (Fig. 4F). 
 
During the initial 1 to 2 min of a recording, P2Y receptor-evoked fibrinogen binding was 
distributed evenly around the plasma membrane of the MK. However, in many recordings, the 
pattern of fibrinogen binding then progressively shifted toward one side of the cell (Fig. 5A). This 
behavior was not observed after stimulation with ionomycin, which induced a non-waveform, 
sustained [Ca2+]i increase and an even distribution of bound fibrinogen around the periphery of 
the MK throughout the duration of the experiment (Fig. 5B). Development of fibrinogen polarity 
was analyzed by calculating a fibrinogen polarity score for each MK. A score of 1 represents a MK 
in which 100% of the fibrinogen bound to one 120o sector of the cell surface, whereas a value of 
0 indicates that the fibrinogen is evenly distributed over the membrane surface. Development of 
polarity peaked approximately 6 min after stimulation with ADPβS (Fig. 5C). As observed for the 
net direction of the Ca2+ waves, ADPβS-evoked fibrinogen binding polarity scores displayed 
marked heterogeneity, ranging from 0.08 to 0.73 (Fig. 5D). Despite the heterogeneity, the 
average fibrinogen polarity score for ADPβS (mean: 0.34 ± 0.24) was statistically significantly 
higher than that observed in response to ionomycin, which induced a consistently low value 
(mean = 0.15 ± 0.07). 
 
After stimulation with ADPβS, MKs with low Ca2+ polarity scores retained a uniform distribution 
of fibrinogen binding at their periphery (Fig. 6, A to C). In contrast, MKs with a high Ca2+ polarity 
score displayed a shift in their fibrinogen binding towards one hemisphere (Fig. 6, D to F). Linear 
regression analysis of the Ca2+ and fibrinogen polarity scores confirmed a statistically significant 
positive correlation (gradient = 0.6; P < 0.001) between these two parameters (Fig. 6G). For 
strongly polarized MKs (fibrinogen polarity scores > 0.5), the average point of origin of Ca2+ waves 
coincided with the side of the cell displaying the center of fibrinogen polarity [mean difference 
of 18 ± 5.6° between the origin of the [Ca2+]i waves and the center of fibrinogen polarity (Fig. 
6H)]. This indicates that the side of the MK from which most of the [Ca2+]i waves originated was 
also the location at which fibrinogen accumulated. 
 
Mobility and reorganization of activated αIIbβ3 depends on its association with the actin 
cytoskeleton 
Inside-out activation of integrins such as αIIbβ3 causes association with the actin cytoskeleton 
through talin (51-54), which limits the mobility of these adhesive receptors within the plasma 
membrane (55). If αIIbβ3 is unable to diffuse freely, cytoskeletal reorganization might form part 
of the mechanism underpinning the development of its polarized distribution. We therefore 
investigated the diffusive properties of activated αIIbβ3 using fluorescence recovery after 
photobleaching (FRAP) of Alexa Fluor 647–labelled fibrinogen bound to the plasma membrane 4 
min after stimulation with ADPβS (Fig. 7A). The fluorescence recovered to only 24 ± 7.5% of pre-
bleached levels by the end of the 220-s recording (Fig. 7, B and C), suggesting that most of th 
αIIbβ3 receptors were immobile within the plasma membrane. Thus, diffusion of the integrin is 
unlikely to be an important factor in the development of polarity. To test whether the association 
of αIIbβ3 with the cytoskeleton limited its mobility, we repeated the FRAP measurements after 
treatment with cytochalasin D, an inhibitor of actin polymerization (Fig. 7, B and C). Diffusion of 
bound fibrinogen was statistically significantly increased by cytochalasin D treatment (mean 
recovery = 36 ± 13%), suggesting that the actin cytoskeleton has a role in limiting the plasma 
membrane mobility of activated αIIbβ3 and that major changes in αIIbβ3 localization are likely to 
occur only through reorganization of the actin cytoskeleton. 
 
To further investigate the relationship between activated αIIbβ3 and the actin cytoskeleton, MKs 
stimulated with ADPβS for 4 min in the presence of Alexa Fluor 647–labeled fibrinogen were fixed 
and stained with Alexa Fluor 488–conjugated phalloidin. Confocal z-stack images showed that 
MKs without polarized fibrinogen binding also lacked polarization of actin structure in three 
dimensions (Fig. 7, D and E). In contrast, MKs in which the bound fibrinogen shifted to one side 
of the cell also displayed an increase in actin abundance in the same cellular hemisphere (Fig. 7, 
F and G). These data suggest that repetitive [Ca2+]i waves can drive directional reorganization of 
actin, leading to spatial redistribution of activated integrin αIIbβ3 at the cell surface. 
 
Discussion 
Regulation of integrin affinity, referred to as “inside-out” signaling, enables cells to control their 
interactions with the extracellular environment. Inside-out signaling is a process common to all 
integrins and involves a conformational change triggered by intracellular events that results in 
exposure of high-affinity sites for ligand binding. αIIbβ3 has long served as a model for the cellular 
regulation of integrins and is highly abundant in platelets and their precursor cell, the MK. 
Although the critical events that underpin receptor-evoked αIIbβ3 activation are well-established, 
the temporal regulation of inside-out signaling has not been explored in detail. Rapid activation 
of integrins is likely to be important in a number of contexts, not least under the dynamic 
conditions present in the circulation where the platelet must activate αIIbβ3 quickly enough to 
enable adhesion at sites of vascular injury. Primary MKs express functional αIIbβ3 that undergoes 
inside out activation upon stimulation with ADP (24, 25) and, unlike in the diminutive platelet, it 
is possible to discern the quantal increase in integrin activation triggered by individual Ca2+ 
transients (Fig. 1). This has enabled us to dissect the temporal relationship between Ca2+ signaling 
events and integrin activation in detail. 
 
We found that the activation of αIIbβ3 was efficiently induced by individual cytosolic Ca2+ 
transients after co-stimulation of the ADP receptors P2Y1 and P2Y12. Two characteristics of 
repetitive Ca2+ transients were found to control the overall rate of integrin activation. First, the 
amplitude of the whole-cell Ca2+ transient determined the magnitude of the increase in integrin 
αIIbβ3 activation after each transient. Second, due to constitutive deactivation of the integrin, the 
net change in integrin activation over time was controlled by the frequency of the Ca2+ transients. 
Another example of a downstream functional event that is controlled by the amplitude and 
frequency of Ca2+ transients is lymphocyte gene transcription (11, 56). Lymphocyte transcription 
factors are regulated differentially by the precise characteristics of Ca2+ oscillations and provide 
a basis for the selective stimulation of individual gene regulation pathways downstream of a 
single second messenger. Several studies showed that the pattern of Ca2+ increase in platelets 
can be specific to individual agonists (57-59) and the relationship between Ca2+ transients and 
integrin activation described in the present study may therefore represent a mechanism whereby 
different agonist species activate integrins with varying levels of efficiency. In addition, because 
the frequency of Ca2+ oscillations in rat MKs increases with agonist concentration (60), this 
provides a mechanism whereby the extent of inside-out activation can be controlled by stimulus 
strength. 
 
Although we found evidence that integrin activation and fibrinogen binding were reversible, the 
rate of release was much slower than that of binding, resulting in the accumulation of bound 
fibrinogen even at low Ca2+ transient frequencies. As a result, the pattern of fibrinogen binding 
bore a strong resemblance to the cumulative Ca2+ signal, suggesting that the accumulation of 
Ca2+-activated intracellular signaling molecules supports inside-out activation. In other cell types, 
transient Ca2+ signaling events are ”memorized” by Ca2+-sensing signaling molecules that are 
rapidly activated but slowly deactivated (61). For example, in T-cells, the Ca2+-calmodulin–
dependent phosphatase calcineurin is activated by Ca2+ transients and subsequently 
dephosphorylates the transcriptional regulator NFAT, enabling its translocation to the nucleus 
(11). Deactivation of NFAT by phosphorylation occurs slowly, such that the interval between Ca2+ 
transients controls the accumulation or loss of nuclear NFAT, resulting in a pattern that is highly 
reminiscent of integrin activation by Ca2+ transients in the MK. In platelets and MKs, the Ca2+-
sensing molecule CalDAGGEFI mediates the activation of Rap1, which in turn mediates integrin 
activation (3). Rap1 is inactivated by the GTPase-activating protein (GAP) RASA3 (62), and it is 
possible that the interplay between CalDAGGEFI, Rap1, and RASA3 regulates integrin activation 
in response to Ca2+ transients in a manner analogous to NFAT regulation in T-cells. 
 
The two ADP receptors expressed in MKs and platelets, P2Y1 and P2Y12, regulate different halves 
of the CalDAGGEFI-RASA3 axis that controls Rap1 activity. We exploited this by using receptor 
antagonists to explore the regulatory roles of P2Y1 and P2Y12 alone and in combination. The Gq-
coupled P2Y1 receptor stimulates activation of PLCβ and Ca2+ transients that switch on the GTP-
exchange activity of CalDAGGEFI, thereby promoting activation of the Ras-like small GTPase Rap1 
(3, 4). Inside-out αIIbβ3 activation by ADP also requires co-activation of P2Y12-induced signals (Fig. 
2) (34, 63). Although this Gi-coupled receptor is linked to the inhibition of AC and the activation 
of Akt, the crucial P2Y12 signaling event is the inactivation of RASA3 GAP activity that tonically 
limits GTP-loading of Rap1 (5). RASA3 inactivation is induced by P2Y12-evoked PI3K activation, 
which is why LY294002 mimics the inhibitory effect of P2Y12 antagonists on ADP-evoked 
fibrinogen binding and Ca2+ responses (Figs. 2F and 3E) (44). Whereas Rap1 and RASA3 are 
already predominantly located at the plasma membrane (7, 64, 65), CalDAGGEFI and talin require 
translocation to the cell membrane during inside-out activation of αIIbβ3 (66-68), which could 
therefore account for a substantial portion of the delay between the Ca2+ transients and integrin 
activation that we observed (Fig. 2). Although P2Y12 antagonists completely blocked the ADP-
induced activation of αIIbβ3 even in the continued presence of Ca2+ transients, substantial 
fibrinogen binding was observed after the induction of a prolonged Ca2+ increase with ionomycin. 
This is consistent with the ability of the Ca2+ ionophore to induce Rap1 activation in platelets (69) 
and indicates that sustained CalDAGGEFI activation can overcome tonic RASA3 activity, although 
there remains a contribution from PI3K activation (Fig. 3I). However, the effect of an [Ca2+]i 
increase alone on fibrinogen binding occurred with a marked delay compared to that observed 
after ADP-evoked Ca2+ transients during P2Y1 and P2Y12 co-stimulation. Indeed, the delay after 
ionomycin-induced Ca2+ increases (23.9 s) was longer than the duration of individual ADP-evoked 
Ca2+ transients (2.5 to 3 s). Thus, the synergy between CalDAGGEFI and RASA3 in promoting Rap1 
activity enables brief Ca2+ transients to stimulate a discrete increase in integrin activation. 
 
Preventing excessive and toxic activation of Ca2+ -dependent proteins (70, 71) is envisaged to be 
one advantage of repetitive transients over sustained increases in this ubiquitous second 
messenger and thus is a further advantage of the P2Y1-P2Y12 synergy occurring at the level of 
Rap1 activation. We noted that rapid fibrinogen binding was not observed after co-stimulation 
of cells through P2Y12 and ionomycin, which suggests that either a difference between the Ca2+ 
increases evoked by P2Y1 and ionomycin or an additional signal downstream of the Gq-coupled 
receptor accelerates Rap1 activation alongside PI3K activation. However, PKC activation was not 
involved (Fig. 3D), consistent with the lack of a role for DAG in CalDAGGEFI activation (72, 73). 
Furthermore, inhibition of PLC mimicked the effect of BAPTA-loading; thus, possibilities for the 
missing signal include IP3 formation or a decrease in PIP2 abundance, which requires further 
investigation. 
 
As previously observed in the MK (23), each P2Y-evoked Ca2+ transient was initiated at one edge 
of the cell and spread as a wave across the remainder of the cytoplasm before declining to resting 
levels. A higher density or greater sensitivity of IP3 receptors at the site of origin of the wave has 
been suggested to account for the point of initiation, which then evokes Ca2+-induced Ca2+ 
release through nearby IP3 receptors, resulting in a spread of the cytosolic Ca2+ increase across 
the cell (23, 74). In the MK, the wave origin has a predominant juxtanuclear location (23) and, 
together with previous observations that the polyploidic nucleus is predominantly located in one 
hemisphere of the cell (23), provides the basis for the polarity of the Ca2+ signal relative to the 
cell structure. Thus, the dependence of the fibrinogen binding on the direction of the Ca2+ wave 
could serve as a signal for directional migration of the MK to the sinusoidal blood vessels where 
proplatelet extension are projected across the vascular endothelium enabling release of new 
platelets into the circulation, for which polarization is critical (75). Indeed, polarized regulation 
of the small GTPases Cdc42 and RhoA stimulates the GPIb-dependent transendothelial migration 
of MKs into the circulation (76). Furthermore, deletion of the two main platelet isoforms of Rap1 
causes reduced proplatelet formation and thus macrothrombocytopenia (77). 
 
In conclusion, here, we examined the relationship between spatiotemporal increases in 
intracellular Ca2+ and activation of high-affinity fibrinogen binding sites of the most prevalent 
platelet integrin, αIIbβ3. The work demonstrates that synergy between P2Y1 and P2Y12 receptors 
accelerates Ca2+-dependent inside-out activation of αIIbβ3 to enable individual P2Y1-evoked 
transient Ca2+ waves to stimulate discrete increases in fibrinogen binding. Spatiotemporal 
information encoded within the repetitive Ca2+ waves determined the extent of fibrinogen 
binding and also redistribution of the active integrin within the cell membrane. 
 
Materials and Methods 
Preparation of rat bone marrow megakaryocytes 
Rat bone marrow was extracted from the tibia and femurs of adult male Wistar rats weighing 
between 300 and 400g. Rats were killed by cervical dislocation in accordance with Home Office 
license regulations and the University of Leicester Home Office certificate of designation. The 
femurs and tibia were isolated, the epiphyses removed, and the marrow was then flushed out 
with 1 ml of Hanks’ Balanced Salt Solution (HBSS). 
 
Simultaneous fluorescence imaging of [Ca2+]i and fibrinogen binding in primary rat MKs 
A bone marrow suspension was diluted 10-fold in HBSS (with 1.26 mM CaCl2) containing 2 µM 
Fluo-3 AM and 0.02% Pluronic F127, incubated for 1 hour at room temperature with gentle 
agitation, pelleted by centrifugation at 200g, and resupended in HBSS. Alexa Fluor 647–labelled 
fibrinogen (centrifuged at 13,600 g for 10 min to remove precipitates) was added at a final 
concentration of 60 µg/ml. MKs were identified by their uniquely large size (diameter >25 μm) 
and multilobular nucleus (78) and were imaged with an Olympus IX81 inverted confocal laser 
scanning microscope (Olympus, UK) and a 60x oil immersion 1.35 NA UPLSAPO objective. Cells 
were mounted in a 200-μl volume chamber (Digitimer Ltd, Welwyn Garden City, UK) in a stable 
“Z” temperature-regulated holder (Bioptechs Inc, Butler, PA) set to 25oC. Images were captured 
at 5.4 Hz with a 6X digital zoom at a resolution of 128 x 128 pixels for a total of 9 min. MKs were 
preincubated for 10 min with MRS2179 (100μM), Cangrelor (1μM), LY294002 (50μM), SQ 22536 
(30μM), U73343 (10μM), U73122 (10μM), or GF109203 (10μM) as described in the figure 
legends. MKs were incubated with 10 μM BAPTA-AM for 60 min to chelate intracellular Ca2+ in 
some experiments as described. Stimulation with 100 μM ADPβS or 1 μM ionomycin was 
achieved by direct addition of these compounds to the chamber with an air-displacement pipette 
held in position by a retort stand. 
 
Solutions and chemicals 
Hanks’ Balanced Salt Solution (HBSS) contained 1.26 mM CaCl2, 0.493 mM MgCl2, 0.407 mM 
MgSO4, 5.33 mM KCl, 0.441 mM KH2PO4, 4.17mM NaHCO3, 137.93 mM NaCl, 0.338 mM Na2HPO4, 
5.56 mM D-glucose, 5 mM HEPES (pH 7.35) with NaOH. Pluronic F127, MRS2179, cytochalasin D, 
LY294002, formyl saline, and ADPβS were obtained from Sigma-Aldrich (Gillingham, UK). Fluo-3 
AM, Alex Fluor 488–conjugated phalloidin and Alexa Fluor 647–conjugated fibrinogen were from 
Invitrogen (Paisley, UK). SQ 22536, U73343, and U73122 were from Tocris Bioscience (Bristol, 
UK). Cangrelor was a kind gift from AstraZeneca (Moindal, Sweden). 
 
Temporal analysis of whole-cell Ca2+ increases and fibrinogen binding 
Temporal changes in intracellular Ca2+ and fibrinogen binding across the entire cell were analyzed 
with ImageJ software (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, 
Maryland, USA, https://imagej.nih.gov/ij/, 1997-2016). Mean fluorescence intensity values were 
measured within a circular region of interest (ROI) containing the entire MK. Background-
subtracted Fluo 3 fluorescence values (F) were converted to F/F0 ratios to normalize for the 
amount of fluorescence before the addition of agonist (F0). Increases in Alexa Fluor 647–
conjugated fibrinogen fluorescence are expressed as the change in signal above that under pre-
stimulated conditions (F-F0). 
 
Calculation of Ca2+ wave and fibrinogen binding polarity scores 
Ca2+ wave direction was assigned to one of eight directions (representing 45o sectors of the MK) 
and used to calculate the average wave direction and magnitude (Ca2+ polarity score) using vector 
analysis similar to that used to calculate average wind direction and speed (79). The following 
equations were used for the vector analysis: 
Equation 1: 
𝑢𝑢�⃗  =  − 𝑢𝑢𝑖𝑖  × sin �2𝜋𝜋 × 𝜃𝜃𝑖𝑖360� 
Equation 2: 
?⃗?𝑣  =  − 𝑢𝑢𝑖𝑖  × cos �2𝜋𝜋 × 𝜃𝜃𝑖𝑖360� 
Equation 3: 
𝐶𝐶𝐶𝐶2+𝑃𝑃𝑃𝑃𝑃𝑃𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑆𝑆𝑆𝑆𝑃𝑃𝑃𝑃𝑆𝑆 =  (𝑢𝑢�⃗  2 +  ?⃗?𝑣2)12 
Equation 4: 
𝐶𝐶𝐶𝐶2+ 𝑊𝑊𝐶𝐶𝑣𝑣𝑆𝑆 𝐷𝐷𝑃𝑃𝑃𝑃𝑆𝑆𝑆𝑆𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 = arctan�𝑢𝑢�⃗
?⃗?𝑣
� ± 180 
 
Equations 1 and 2 calculate vector components (𝑢𝑢�⃗  and ?⃗?𝑣) using vector magnitude (𝑢𝑢𝑖𝑖  - assigned 
an arbitrary value of 1) and wave direction in degrees (𝜃𝜃𝑖𝑖). Equation 3 calculates the average 
vector magnitude (Ca2+ Polarity Score) using the mean 𝑢𝑢�⃗  and ?⃗?𝑣 for all of the Ca2+ waves measured 
in a single MK. Equation 4 calculates the mean Ca2+ Wave Direction using mean 𝑢𝑢�⃗  and ?⃗?𝑣, where 
180o is added if arctan �𝑢𝑢�⃗
𝑣𝑣�⃗
� is < 180 and 180o is subtracted if  arctan �𝑢𝑢�⃗
𝑣𝑣�⃗
� > 180. 
Fibrinogen polarity was quantified by first identifying the 120o sector of each MK that had 
developed the greatest fluorescence intensity 6 min after stimulation. The sum fluorescence 
intensity of this sector (Fsectmax) and the total fluorescence intensity of the entire MK (FWC) were 
used to calculate the degree of fibrinogen polarity with Equation 5. 
Equation 5: 
𝐹𝐹𝑃𝑃𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝐹𝐹𝑆𝑆𝑃𝑃 𝑃𝑃𝑃𝑃𝑃𝑃𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =  𝐹𝐹𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠  × 3
𝐹𝐹𝑤𝑤𝑠𝑠
− 1 
 
FRAP measurements 
MKs were preincubated with 10 μM cytochalasin D or vehicle and then stimulated for 2 min with 
100 µM ADPβS in the presence of 60 µg/ml Alexa Fluor 647–labelled fibrinogen. The labelled 
fibrinogen was then bleached by exposure to a 635-nm laser at maximum intensity for 300 ms 
within a 16-µm2 circular region at the cell periphery. Recovery of fluorescence was monitored by 
confocal imaging (Olympus FV1000, see above) at a rate of 0.2 Hz for 220 s. Longer recordings 
could not be performed because this assay was particularly sensitive to the small movements of 
MKs that naturally occur over time. Data were analyzed with the following equation to correct 
for nonspecific bleaching and normalize to the pre-bleach and post-bleach fluorescence intensity 
values: 
 
Equation 6: 
𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑆𝑆𝑁𝑁 𝐵𝐵𝐵𝐵 =  �𝐵𝐵𝐵𝐵 − 𝐵𝐵𝐹𝐹𝑅𝑅𝐵𝐵 − 𝐵𝐵𝐹𝐹� −  �𝐵𝐵𝐹𝐹 − 𝐵𝐵𝐹𝐹𝑅𝑅𝐹𝐹 − 𝐵𝐵𝐹𝐹� 
�
𝐵𝐵𝑃𝑃 − 𝐵𝐵𝐹𝐹
𝑅𝑅𝑃𝑃 − 𝐵𝐵𝐹𝐹� −  �𝐵𝐵𝐹𝐹 − 𝐵𝐵𝐹𝐹𝑅𝑅𝐹𝐹 − 𝐵𝐵𝐹𝐹�  
where Bx is the fluorescence intensity of the bleached ROI at x s, Bb is the fluorescence intensity 
of the bleached ROI immediately after photobleaching, Bi is the initial fluorescence intensity of 
the bleached ROI at, Rx is the fluorescence intensity of the reference ROI (non-bleached region 
of the MK), Rb is the fluorescence intensity of the reference ROI immediately after 
photobleaching, Ri is the initial fluorescence intensity of the reference ROI, and Bg is the average 
fluorescence intensity of the background ROI. 
 
Immunocytochemistry 
MKs suspended in HBSS with 60 µg/ml Alexa Fluor 647–labelled fibrinogen were stimulated with 
100 µM ADPβS for 6 min and then fixed in 8% formyl saline for 10 min. Cells were washed in 
HBSS, permeablized with 0.2% triton X-100 for 10 min, and then washed again in HBSS. Cells were 
blocked for 1 hour in 1% w/v bovine serum albumin (BSA) and stained for 1 hour with Alexa Fluor 
488–conjugated phalloidin (1:1000) in 1% BSA. Cells were then washed three times in HBSS and 
imaged with a 60X objective lens on a Nikon F1000 confocal microscope. 
 
Statistical analysis 
Statistical testing was performed as described in the individual figure legends with GraphPad 
Prism software (La Jolla, Ca). 
 
Supplementary Materials 
Movie S1. Intracellular Ca2+ signaling and fibrinogen binding after stimulation with ADPβS. 
Movie S2. Intracellular Ca2+ signaling and fibrinogen binding after stimulation with ionomycin. 
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Fig. 1. Integrin αIIbβ3 activation is dependent upon the timing and magnitude of ADPβS-evoked, 
repetitive Ca2+ transients. (A to F) Characteristics of the [Ca2+]i transients and fibrinogen 
accumulation as measured by confocal fluorescence microscopy analysis of primary rat MKs after 
stimulation with ADPβS at the indicated times. Whole-cell images (A) and fluorescence traces (B 
to D) of the cytoplasmic Ca2+ concentration (blue) and peripheral fibrinogen binding (red) are 
representative of six independent experiments performed in duplicate. Fibrinogen binding 
events were quantified in terms of the peak increase (Peak ΔF) and net change (Net ΔF). (E and 
F) Linear regression analysis of quantified maximal fibrinogen-binding events (Peak ΔF) versus 
Peak Ca2+ F/F0 (E) or the net change in fibrinogen binding (Net ΔF) versus Ca2+ Transient Interval 
(F). Relationships for individual experiments are shown by the gray lines and the average of all 
experiments is indicated by the red line. *P < 0.05 by Pearson correlation. 
 
Fig. 2. Rapid activation of integrin αIIbβ3 is dependent on synergy between P2Y1 and P2Y12 
receptors. (A to I) Confocal fluorescence microscopy analysis of [Ca2+]i transients and fibrinogen 
accumulation in primary rat MKs after stimulation with ADPβS (A to F) or ionomycin (G to I) over 
the indicated times. Responses are representative of at least three independent experiments. 
The blue traces represent the whole-cell intracellular Ca2+ responses and the red traces represent 
peripheral fibrinogen binding. (D) The cumulative integrated Ca2+  increase (green) alongside Ca2+ 
and fibrinogen responses during the initial four Ca2+ transients of the experiment shown in (A). 
(A to D) Responses to ADPβS were compared after cytoplasmic loading with the Ca2+ chelator 
BAPTA (C), incubation with the P2Y1 antagonist MRS2179 (E), incubation with the P2Y12 
antagonist Cangrelor (F), or exposure to vehicle as a control (B). (H and I) Responses to ionomycin 
after incubation with vehicle (H) compared to responses to ionomycin and ADPβS when MKs had 
been treated with MRS2179 (I). (J) Quantification of the mean lag period between the onset of 
[Ca2+]i flux and fibrinogen binding in response to ADPβS or ionomycin with or without MRS2179 
or Cangrelor. Data are means ± SD of at least three independent experiments. ***P < 0.001 by 
one-way ANOVA with Tukey’s multiple comparisons test; n.s., not significant; n/a, not applicable 
due to complete inhibition. 
 
Fig. 3. Enhanced [Ca2+]i and activation of PI3K are required for rapid αIIbβ3 activation. (A to K) 
Confocal fluorescence microscopy analysis of [Ca2+]i transients and fibrinogen accumulation in 
primary rat MKs after stimulation with ADPβS (A to G) or ionomycin (I to K). Intracellular Ca2+ 
(blue) and fibrinogen binding (red) responses are representative of at least three independent 
experiments  for ADPβS (A to G) and  ionomycin (I to K). Cells were treated with vehicle (A) or the 
specified inhibitors U73122 (B and J), U73343 (C and K), GF109203 (D), LY294002 (E and I) 
SQ22536 (F), or a combination of SQ22536 and Cangrelor (G). For the control ionomycin-evoked 
response, see Fig. 2G. (H) Peak increase in fibrinogen in response to ADPβS for all cells in each of 
the conditions shown in (A) to (G); n ≥ 3 for each condition; bar shows the mean ± SD. *P < 0.05 
by one-way ANOVA with Dunn’s multiple comparisons test. 
 
Fig. 4. Directional polarity of P2Y receptor–evoked Ca2+ waves in MKs. (A to F) Spatial analysis 
of ADPβS-evoked transient [Ca2+]i waves in primary rat MKs. (A to C) Confocal fluorescence 
images showing the progression of a single [Ca2+]i  wave (A) or 10 consecutive waves (B and D). 
(A) Left: The octants used to calculate radar plots and Ca2+ wave score are displayed in the pre-
stimulus image. The progression of a Ca2+ wave is shown by the dotted red lines in subsequent 
images at the stated time after stimulation. (B and D) The red arrows depict the direction of travel 
of individual waves, whereas a dotted circle represents Ca2+ increases that lacked a clear direction 
of travel across the cell. The extent to which all waves within a single cell displayed a net polarity 
is summarized within radar plots based upon the percentage of [Ca2+]i  waves travelling towards 
each octant (C andE). (B and C) Images and analysis of an MK with a low polarity score. (D and E) 
Images and analysis of an MK with a high Ca2+ polarity score. (F) Quantification of the Ca2+ polarity 
score calculated for 12 MKs measured in seven independent experiments. 
 
Fig. 5. Development of a polarized integrin αIIbβ3 distribution after stimulation by ADPβS, but 
not ionomycin. (A to D) Confocal fluorescence microscopy analysis of fibrinogen binding to 
primary rat MKs after stimulation with ADPβS or ionomycin. Fluorescence intensity radar plots 
(top) and confocal images (bottom) of surface-bound fibrinogen in a single MK before and at 2-
min intervals after stimulation with ADPβS (A) or ionomycin (B). (C) Quantification of the 
fibrinogen polarity score against time after stimulation with ADPβS [red line corresponding to the 
cell shown in (A)] or ionomycin [blue line corresponding to the cell shown in (B)]. (D) A scatter 
plot comparing fibrinogen polarity scores calculated 6 min after stimulation with ADPβS (n = 12) 
or ionomycin (n = 10). Data are means ± SD; *P < 0.05 by Students t test. The cells selected in (A) 
and (C) show representative data from an MK with a high polarity score after stimulation with 
ADPβS (n = 6) and all MKs after treatment with ionomycin (n = 10). 
 
Fig. 6. Ca2+ wave direction coordinates the polarization of activated integrin αIIbβ3. (A to G) 
Confocal fluorescence microscopy and analysis of the relationship between [Ca2+]i waves and 
fibrinogen binding in primary rat MKs after stimulation with ADPβS. (A to C) Representative cell 
showing low polarity scores for both Ca2+ wave direction and fibrinogen binding. (D to F) 
Representative of a cell with high polarity scores for both parameters. Radar plot analysis (A, B, 
D, and E) of Ca2+ wave direction (A and D) and fibrinogen binding (B and D) together with 
fluorescence images of fibrinogen binding (C and F) before and every 2 min after stimulation. (G) 
Linear regression analysis of fibrinogen polarity score against Ca2+ polarity score for 12 MKs, 
which gave a statistically significant non-zero fit (P < 0.05) with a positive gradient (0.59). (H) 
Schematic diagram representing the difference in angle between the average point of origin of 
Ca2+ waves and the center of fibrinogen polarity in 5 MKs that had a fibrinogen polarity score > 
0.5. 
 
Fig. 7. The mobility and distribution of activated αIIbβ3 in the plasma membrane are dependent 
on its association with the actin cytoskeleton. (A to C) FRAP analysis of fibrinogen bound to 
ADPβS-stimulated MKs as measured by confocal fluorescence microscopy. (A) Images of 
fibrinogen bound to an ADPβS-stimulated MK before and immediately after bleaching of a 
defined region (dotted circle) at the cell periphery. (B) Normalized fluorescence recovery over 
time within the bleached region after treatment with vehicle (black line) or cytochalasin D (red 
line). The responses are representative of six independent experiments. (C) Average maximum 
recovery of fluorescence within the bleached region after 4 min. Data are means ± SEM of six 
independent experiments. (D to G) Confocal fluorescence analysis of fibrinogen binding (red) and 
actin (green) in MKs fixed 4 min after stimulation with ADPβS. Data are representative of an MK 
with either a low (D and E) or a high (F and G) fibrinogen polarity score, taken from three 
independent experiments. (D and F) Seven consecutive fluorescence images at 1-µm intervals 
from a z-stack and with a 3D reconstruction of the whole MK (right panel). (E and G) Radar plots 
of normalized fluorescence intensity for fibrinogen and actin around the circumference of the 
MKs for each confocal slice. *P < 0.05 by Students t test. 
  
   
   
   
   
   
   
 
